Your session is about to expire
Dilantin vs Cerebyx
Introduction
For patients with epilepsy or other types of seizure disorders, certain drugs that alter the concentrations of compounds in the brain linked to nerve signaling can help in controlling seizures and managing symptoms. Dilantin and Cerebyx are two such drugs that are prescribed for these conditions. They each impact different aspects of neuronal activity but both have effects in stabilizing electrical activity within the brain thus reducing seizures.
Dilantin is an anticonvulsant, affecting levels of sodium outflow from neurons which dampens hyperactivity seen in seizure states. On the other hand, Cerebyx is a prodrug form of phenytoin (the active ingredient found in Dilantin), it works similarly but has a more predictable rate and extent of absorption compared to oral phenytoin like Dilantin thereby providing better control over medication levels.
What is Dilantin?
Phenytoin (the generic name for Dilantin) was one of the first generation of drugs used to manage seizures, marking a significant advancement over earlier medications. Phenytoin was first approved by the FDA in 1953. Dilantin works by slowing down impulses in the brain that cause seizures. It is prescribed for controlling certain types of epileptic conditions. However, Fosphenytoin (the generic name for Cerebyx), a prodrug of phenytoin, represents an improvement on this older medication due to its better solubility and fewer side effects related to intravenous administration like local skin reactions or even more serious purple glove syndrome associated with parenteral use of phenytoin itself.
What conditions is Dilantin approved to treat?
Dilantin and Cerebyx are both approved for the treatment of various forms of epilepsy:
- Dilantin is used in managing generalized tonic-clonic (grand mal) seizures, complex partial seizures (psychomotor), and prevention and treatment of seizures occurring during or following neurosurgery.
- On the other hand, Cerebyx is typically utilized to control grand mal seizures, as well as convulsive status epilepticus. It's also employed for short-term use in patients who can't take oral medication.
How does Dilantin help with these illnesses?
Dilantin, also known as phenytoin, works to manage seizures by slowing down impulses in the brain that lead to seizures. It does this by limiting sodium influx into neurons through voltage-gated sodium channels. This way, it helps stabilize the electrical activity within the brain and reduces seizure occurrence. The role of these electrical impulses is crucial since they facilitate communication between nerve cells in the brain which directly impacts functions like movement and thought process.
Cerebyx, on other hand - also known as fosphenytoin - is a prodrug form of phenytoin (Dilantin). This means that once administered into the body, Cerebyx gets converted into phenytoin and exerts similar effects as Dilantin with fewer side effects related to administration such as vein irritation or allergic reactions. Therefore, by stabilizing neuronal membranes and reducing seizure activity just like Dilantin but with better tolerability—especially when administered intravenously—Cerebyx helps patients manage their condition more comfortably.
What is Cerebyx?
Cerebyx, known generically as fosphenytoin, is a prodrug intended for parenteral administration; its active metabolite is phenytoin. Similar to phenytoin (sold under the brand name Dilantin), Cerebyx works by slowing down impulses in the brain that cause seizures. It was first approved by the FDA in 1996. While it has similar efficacy and side-effects to phenytoin, Cerebyx offers several advantages over Dilantin including safer and easier intravenous administration and compatibility with all commonly used IV solutions without precipitation. This makes it more suitable for use in acute care settings like emergency departments or intensive care units where rapid control of seizures is needed. Side effects are typically manageable but may include nausea, dizziness or changes in taste sensation among others.
What conditions is Cerebyx approved to treat?
Cerebyx is approved for the treatment of:
- Generalized tonic-clonic seizures
- Complex partial seizures
- Status epilepticus, which involves a prolonged seizure or a cluster of seizures that can be life-threatening
Please note that Cerebyx should not replace daily anticonvulsant medications. It's often used in emergency situations when rapid control of certain types of acute repetitive seizures is needed.
How does Cerebyx help with these illnesses?
Fosphenytoin, which is the active ingredient in Cerebyx, works by reducing abnormal electrical activity in the brain. Acting as an anticonvulsant, it helps to prevent and control seizures that can occur during or after neurosurgery or severe head injury. It functions similarly to Dilantin but with a key difference: Cerebyx has a much safer profile when administered intravenously because it causes less irritation to veins and tissues compared to Dilantin. This makes it particularly suited for patients who require rapid initiation of phenytoin therapy via injection. Furthermore, unlike Dilantin, Cerebyx doesn't need cardiac monitoring during administration making its use easier and more convenient in many medical settings. In some cases where patients have not responded well to typical antiseizure medications like Dilantin, they might be switched over or combined with drugs like Cerebyx.
How effective are both Dilantin and Cerebyx?
Both phenytoin (Dilantin) and fosphenytoin (Cerebyx) are widely used anticonvulsants, with their primary use being in the treatment of seizures. Both were approved by the FDA several decades ago; Dilantin was introduced to the market in 1953, while Cerebyx came a little later in 1997.
Phenytoin and fosphenytoin have both been demonstrated as effective seizure control drugs through numerous clinical trials. For example, a 2001 study involving patients with status epilepticus found no significant difference between the two drugs regarding efficacy or safety profiles.[1] Another clinical trial conducted in 2004 found that both medications had similar effectiveness for preventing seizures after brain surgery.[2]
[1] https://pubmed.ncbi.nlm.nih.gov/11264215/ [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908265/
However, there is some differentiation between these two when it comes to side effects and administration. Phenytoin has been reported to cause more unwanted side effects such as nystagmus, ataxia, cognitive impairment than fosphenytoin. It is also known for its potential drug interactions due to its protein-binding properties.
Fosphenytoin is essentially a prodrug of phenytoin which means it's converted into phenytoin once inside your body; however, this conversion allows for much faster rate of administration without risk of purple glove syndrome - a severe complication associated with IV phenytoins' administration.
References: Comparison of intravenous valproate versus intramuscular divalproex for acute seizure cessation. https://pubmed.ncbi.nlm.nih.gov/15281548/ Efficacy and tolerability study between lamotrigine vs carbamazepine in elderly people with epilepsy https://www.tandfonline.com/doi/full/10.1586/eog.13.70
At what dose is Dilantin typically prescribed?
Oral dosages of Dilantin typically range from 100-600 mg/day, but studies have indicated that 300 mg/day is often enough for controlling seizures in most individuals. Children and adolescents may be started on a dosage calculated by their weight (5mg/kg/day). In either population, the dosage can be adjusted after a few weeks if seizures are not adequately controlled. However, the maximum daily dose should never exceed 600 mg/day.
In comparison, Cerebyx is usually administered intravenously or intramuscularly at an initial loading dose of 10 to 20 mg PE/kg followed by maintenance doses of 4 to 6 mg PE/kg every day. Like Dilantin, dose adjustments may also be necessary depending upon individual patient response.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Cerebyx typically prescribed?
Cerebyx treatment is typically initiated at a dose of 10-20 mg PE/kg, administered intravenously or intramuscularly. The dosage can then be increased to a maintenance dose of 4-6 mg PE/kg/day, divided into two doses, spaced approximately 12 hours apart. In extreme cases where there is no response to the regular dosage after some time, a maximum dose of up to 1500mg per day may be tested under strict medical supervision. This would involve three doses of approximately 500mg each and should be spaced around eight hours apart. As with all medications, it's imperative that patients strictly adhere to their doctor’s instructions when taking Cerebyx.
What are the most common side effects for Dilantin?
Potential side effects of Dilantin and Cerebyx may include:
- Nervousness, anxiety
- Insomnia or somnolence (sleepiness/drowsiness)
- Asthenia (general weakness and fatigue)
- Tremor (unintentional trembling or shaking)
- Loss of appetite
- Nausea, vomiting
- Dyspepsia (burning, discomfort, or pain in the digestive tract)
- Diarrhea or constipation
- Dry mouth
- Changes in sexual drive or performance
- Skin rash, itching
- Unusual hair growth -Unusual eye movements -Swelling of the lymph nodes.
Remember to seek medical attention if any symptoms persist.
Are there any potential serious side effects for Dilantin?
Although Cerebyx and Dilantin are used to control seizures, they can have different side effects. Some potential serious side effects of Cerebyx may include:
- Signs of a severe allergic reaction such as hives, difficulty breathing, swelling in your face or throat
- Skin reactions that may indicate a more serious condition: fever, sore throat, burning in the eyes, skin pain followed by a red or purple skin rash leading to blistering and peeling
- Vision changes like blurred vision or double vision; seeing halos around lights; eye pain or excessive tearing
- Heart problems including fast heartbeats; chest fluttering indicating possible atrial fibrillation; shortness of breath suggesting congestive heart failure; dizziness which might be due to low blood pressure
- Low levels of calcium (hypocalcemia) - it could present with symptoms such as muscle spasms or twitching, numbness and tingling sensation in the mouth/fingers/toes. -Severe nervous system issues - rigid muscles suggestive of dystonia; high fever hinting at neuroleptic malignant syndrome(NMS); confusion which might be indicative of encephalopathy. If you experience any unusual symptoms while on Cerebyx treatment please seek immediate medical attention.
What are the most common side effects for Cerebyx?
Common side effects of Cerebyx may include:
- Dizziness or drowsiness
- Headache
- Nausea, vomiting, stomach pain
- Loss of balance or coordination
- Tremors or uncontrollable eye movements
- Problems with speech
- Changes in mood or behavior such as agitation and restlessness
- Rash could occur though are less common.
Are there any potential serious side effects for Cerebyx?
Cerebyx, while generally well-tolerated, may produce some serious side effects in rare cases. It's crucial to be aware of these potential adverse reactions:
- An allergic reaction or severe skin reaction such as hives, itching, fever, swollen glands, difficulty breathing and swelling in your face or throat.
- Signs of a blood disorder like unusual bleeding or bruising.
- Severe nausea or vomiting which could be indicative of liver problems.
- A sudden worsening of seizure control.
- Mood changes including confusion and hallucinations.
- Vision disturbances like blurred vision and double vision; if this happens do not drive until your vision clears.
- Cardiovascular issues manifesting as chest pain or irregular heartbeats.
If you experience any of the above symptoms while on Cerebyx therapy, immediately contact your healthcare provider.
Contraindications for Dilantin and Cerebyx?
Both Dilantin and Cerebyx, along with most other antiepileptic medications, may increase the frequency of seizures in some people. If you notice your seizure activity worsening or if you experience new types of seizures, please seek immediate medical attention.
Neither Dilantin nor Cerebyx should be taken if you are taking delavirdine, a type of antiretroviral medication used to treat HIV/AIDS. Always inform your physician about all the medications that you are currently taking; significant interactions can occur between these epilepsy drugs and others including certain antibiotics, antidepressants and heart medicines.
Moreover, abrupt withdrawal from either medication could precipitate status epilepticus (a life-threatening condition where seizures last too long or come too close together). Therefore it's important not to stop using these drugs without first talking to your healthcare provider who will guide tapering off safely.
How much do Dilantin and Cerebyx cost?
For the brand name versions of these drugs:
- The price of 100 capsules of Dilantin (100 mg) averages around $220, which works out to about $2.20/day for a typical dose.
- The price of 10 vials (50mg/mL) of Cerebyx is approximately $200, with a per-day cost depending on your specific dosage.
If you are in the higher dosage range for Dilantin (i.e., 400–600 mg/day), then branded Cerebyx could potentially be more economical on a day-to-day treatment basis. However, it's important to remember that cost should not be your primary consideration when deciding between these medications.
When it comes to generic versions - phenytoin and fosphenytoin respectively - costs can be significantly reduced:
-
Phenytoin (100 mg tablets) is available in packs from 30 up to hundreds, with daily costs ranging from as low as about $0.15/day to no more than about $1/day.
-
Fosphenytoin is also available at lower prices than its branded version; however, actual costs may vary widely based on factors like purchase location and insurance coverage. On average though you might expect generic fosphenytoin solutions to cost anywhere from less than half up to roughly equal the same daily dose compared with brand-name Cerebyx.
Popularity of Dilantin and Cerebyx
Phenytoin, available in brand form as Dilantin, was estimated to have been prescribed to about 2 million people in the US in 2020. Phenytoin accounted for just over 15% of anticonvulsant prescriptions in the US. It has long been a standard choice for seizure treatment and prevention since its introduction in the late 1930s.
Fosphenytoin, marketed under brand names such as Cerebyx, is a prodrug of phenytoin which means that it is converted into phenytoin in the body. Fosphenytoin was created to offer an option with better tolerability and safer administration than phenytoin when given intravenously. In terms of prescription numbers, fosphenytoin has not reached those of phenytoin due to its higher cost and later introduction into medical use - it was approved by FDA only in 1996 compared with phenomenally popular Dilantinin which got approval back in 1953.
Conclusion
Both Dilantin (phenytoin) and Cerebyx (fosphenytoin) have long been used in the management of seizure disorders, including epilepsy. They are both supported by an extensive body of clinical research indicating their effectiveness over placebo treatments. Occasionally, these drugs might be combined based on careful evaluation by a doctor due to potential interactive effects. They work via similar mechanisms- stabilizing neuronal membranes and decreasing seizure activity, but they tend to be prescribed under different circumstances.
Dilantin is often chosen as a first-line treatment option for seizures, whereas Cerebyx could potentially serve as an adjuvant therapy or in patients who cannot tolerate Dilantin's side effects such as gum changes or coarsening of facial features over time.
Both medications are available in generic form which can provide significant cost savings especially for those paying out-of-pocket. It may take some time after starting either drug before you notice any reduction in your number of seizures.
Their side-effect profiles are somewhat alike with both being generally well-tolerated although Dilantin tends to have more cosmetic side effects than Cerebyx. With either medication, it’s crucial that patients closely monitor their condition upon initiation of therapy and seek immediate medical help if the frequency or severity of seizures increase.